Occurrence and distribution of canine cutaneous mast cell tumour characteristics among predisposed breeds

1. Adams V.J., Evans K.M., Sampson J., Wood J.L.: Methods and mortality results of a health survey of purebred dogs in the UK. J Small Anim Pract 2010, 51, 512–524.10.1111/j.1748-5827.2010.00974.x21029096Search in Google Scholar

2. Arendt M.L., Melin M., Tonomura N., Koltookian M., Courtay-Cahen C., Flindall N., Bass J., Boerkamp K., Megquir K., Youell L., Murphy S., McCarthy C., London C., Rutteman G.R., Starkey M., Lindblad-Toh K.: Genome-wide association study of Golden Retrievers identifies germ-line risk factors predisposing to mast cell tumours. PLoS Genet 2015, 11, e1005647.10.1371/journal.pgen.1005647465448426588071Search in Google Scholar

3. Blackwood L., Murphy S., Buracco P., de Vos J.P., de Fornel-Thibaud P., Hirschberger J., Kessler M., Pastor J., Ponce F., Savary-Bataille K., Argyle D.J.: European consensus document on mast cell tumours in dogs and cats. Vet Comp Oncol 2012, 10, e1–e29.10.1111/j.1476-5829.2012.00341.x22882486Search in Google Scholar

4. Boerkamp K.M., Teske E., Boon L.R., Grinwis G.C., van den Bossche L., Rutteman G.R.: Estimated incidence rate and distribution of tumours in 4,653 cases of archival submissions derived from the Dutch golden retriever population. BMC Vet Res 2014, 31, 10–34.10.1186/1746-6148-10-34391470824484635Search in Google Scholar

5. Davis B.W., Ostrander E.A.: Domestic dogs and cancer research: a breed-based genomics approach. ILAR J 2014, 55, 59–68.10.1093/ilar/ilu017415834624936030Search in Google Scholar

6. Dobson J.M.: Breed-predispositions to cancer in pedigree dogs. ISRN Vet Sci 2013, ID: 941275, doi:10.1155/2013/941275.10.1155/2013/941275365842423738139Search in Google Scholar

7. Dobson J.M., Scase T.J.: Advances in the diagnosis and management of cutaneous mast cell tumours in dogs. J Small Anim Pract 2007, 48, 424–431.10.1111/j.1748-5827.2007.00366.x17559522Search in Google Scholar

8. Egenvall A., Bonnett B.N., Hedhammar A., Olson P.: Mortality in over 350,000 insured Swedish dogs from 1995–2000: II. Breed-specific age and survival patterns and relative risk for causes of death. Acta Vet Scand 2005, 46, 121–136.10.1186/1751-0147-46-121162481816261925Search in Google Scholar

9. Erich S.A., Constantino-Casas F., Dobson J.M., Teske E.: Morphological distinction of histiocytic sarcoma from other tumor types in Bernese Mountain Dogs and Flatcoated Retrievers. In Vivo 2018, 32, 7–17.10.21873/invivo.11198589262629275293Search in Google Scholar

10. Grüntzig K., Graf R., Boo G., Guscetti F., Hässig M., Axhausen K.W., Fabrikant S., Welle M., Meier D., Folkers G., Pospischil A.: Swiss Canine Cancer Registry 1955–2008: occurrence of the most common tumour diagnoses and influence of age, breed, body size, sex, and neutering status on tumour development. J Comp Pathol 2016, 155, 156–170.10.1016/j.jcpa.2016.05.01127406312Search in Google Scholar

11. Grüntzig K., Graf R., Hassig M., Welle M., Meier D., Lott G., Erni D., Schenker N.S., Guscetti F., Boo G., Axhausen K., Fabrikant S., Folkers G., Pospischil A.: The Swiss Canine Cancer Registry: a retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008. J Comp Pathol 2015, 152, 161–171.10.1016/j.jcpa.2015.02.00525824119Search in Google Scholar

12. Kandefer-Gola M., Nowak M., Madej J.A., Dzimira S., Ciaputa R., Janus I.: Useful immunohistochemical indicators in canine mast cell tumours Act Vet Hung 2015, 63, 49–59.10.1556/avet.2015.005Search in Google Scholar

13. Kandefer-Gola M., Nowak M., Dzimira S., Janus I., Ciaputa R., Madej J.A.: COX-2 and mPGES-1 expression in canine mast cell tumour. Med Weter 2015 71, 345–348.10.1016/j.jcpa.2014.10.101Search in Google Scholar

14. Kandefer-Gola M., Madej J.A., Dzimira S., Nowak M., Janus I., Ciaputa R.: Comparative analysis of markers of cell proliferation in canine mast cell tumour according to current classifications. Pol J Vet Sci 2015, 18, 241–247.10.1515/pjvs-2015-003126172171Search in Google Scholar

15. Kandefer-Gola M., Madej J.A., Dzimira S., Janus I., Nowak M., Ciaputa R.: Immunohistochemical evaluation of neoangiogenesis in canine mast cell tumours. Bull Vet Inst Pulawy 2015, 59, 247–253.10.1515/bvip-2015-0037Search in Google Scholar

16. Kiupel M., Webster J.D., Bailey K.L., Best S., DeLay J., Detrisac C.J., Fitzgerald S.D., Gamble D., Ginn P.E., Goldschmidt M.H., Hendrick M.J., Howerth E.W., Janovitz E.B., Langohr I., Lenz S.D., Lipscomb T.P., Miller M.A., Misdorp W., Moroff S., Mullaney T.P., Neyens I., O’Toole D., Ramos-Vara J., Scase T.J., Schulman F.Y., Sledge D., Smedley R.C., Smith K., Snyder P., Southorn E., Stedman N.L., Steficek B.A., Stromberg P.C., Valli V.E., Weisbrode S.E., Yager J., Heller J., Miller R.: Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Vet Pathol 2011, 48, 147–155.10.1177/0300985810386469836984921062911Search in Google Scholar

17. Krupa A., Hildebrand W., Kandefer-Gola M., Nowak M., Nicpoń J.: Mast cell tumor. Med Weter 2013, 69, 102–108.Search in Google Scholar

18. Leidinger E.F., Freeman K., Kirtz G., Hooijberg E.H., Sick K.: Breed related odds ratio and anatomic distribution of canine mast cell tumours in Austria. Retrospective study of cases in the years 2000–2010. Tierarztl Prax Ausg K Kleintiere Heimtiere 2014, 42, 367–373.10.15654/TPK-14016525418504Search in Google Scholar

19. Miller D.M.: The occurrence of mast cell tumors in young Shar-Peis. J Vet Diagn Invest 1995, 7, 360–363.10.1177/1040638795007003117578452Search in Google Scholar

20. Mochizuki H., Motsinger-Reif A., Bettini C., Moroff S., Breen M.: Association of breed and histopathological grade in canine mast cell tumours. Vet Comp Oncol 2017, 15, 829–839.10.1111/vco.1222527198171Search in Google Scholar

21. O’Connell K., Thomson M.: Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases. Vet Comp Oncol 2013, 11, 51–62.10.1111/j.1476-5829.2011.00301.x22235766Search in Google Scholar

22. O’Neill D.G., Church D.B., McGreevy P.D., Thomson P.C., Brodbelt D.C.: Longevity and mortality of owned dogs in England. Vet J 2013, 198, 638–643.10.1016/j.tvjl.2013.09.02024206631Search in Google Scholar

23. Olson K.R., Levy J.K., Norby B., Crandall M.M., Broadhurst J.E., Jacks S., Barton R.C., Zimmerman M.S.: Inconsistent identification of pit bull-type dogs by shelter staff. Vet J 2015, 206, 197–202.10.1016/j.tvjl.2015.07.01926403955Search in Google Scholar

24. Patnaik A.K., Ehler W.J., MacEwen E.G.: Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984, 21, 469–474.10.1177/0300985884021005036435301Search in Google Scholar

25. Pizzoni S., Sabattini S., Stefanello D., Dentini A., Ferrari R., Dacasto M., Giantin M., Laganga P., Amati M., Tortorella G., Marconato L.: Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study. Vet Comp Oncol 2017, 16, 28–36.10.1111/vco.1230628233400Search in Google Scholar

26. Polton G.A., Mowat V., Lee H.C., McKee K.A., Scase T.J.: Breed, gender and neutering status of British dogs with anal sac gland carcinoma. Vet Comp Oncol 2006, 4, 125–131.10.1111/j.1476-5829.2006.00100.x19754809Search in Google Scholar

27. Shoop S.J., Marlow S., Church D.B., English K., McGreevy P.D., Stell A.J., Thomson P.C., O’Neill D.G., Brodbelt D.C.: Prevalence and risk factors for mast cell tumours in dogs in England. Canine Genet Epidemiol 2015, 2, 1–10.10.1186/2052-6687-2-1457937026401329Search in Google Scholar

28. Sledge D.G., Webster J., Kiupel M.: Canine cutaneous mast cell tumors: A combined clinical and pathologic approach to diagnosis, prognosis and treatment selection. Vet J 2016, 215, 43–54.10.1016/j.tvjl.2016.06.00327372911Search in Google Scholar

29. Śmiech A., Ślaska B., Łopuszyński W., Jasik A., Szczepanik M., Wilkołek P.: Epidemiological study of canine mast cell tumours according to the histological malignancy grade. Pol J Vet Sci 2017, 20, 455–465.10.1515/pjvs-2017-005529166281Search in Google Scholar

30. Śmiech A., Ślaska B., Surdyka M., Grzybowska-Szatkowska L., Łopuszyński W., Różańska D.: Identification of additional mitochondrial DNA mutations in canine mast cell tumours. Acta Vet Scand 2016, 58, 2–8.10.1186/s13028-016-0210-y485572227146669Search in Google Scholar

31. Villamil J.A., Henry C.J., Bryan J.N., Ellersieck M., Schultz L., Tyler J.W., Hahn A.W.: Identification of the most common cutaneous neoplasms in dogs and evaluation of breed and age distributions for selected neoplasms. J Am Vet Med Assoc 2011, 239, 960–965.10.2460/javma.239.7.96021961635Search in Google Scholar

32. Warland J., Dobson J.: Breed predispositions in canine mast cell tumour: a single centre experience in the United Kingdom. Vet J 2013, 197, 496–498.10.1016/j.tvjl.2013.02.01723583004Search in Google Scholar

33. Welle M.M., Bley C.R., Howard J., Rüfenacht S.: Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment. Vet Dermatol 2008, 19, 321–339.10.1111/j.1365-3164.2008.00694.x18980632Search in Google Scholar

34. White C.R., Hohenhaus A.E., Kelsey J., Procter-Gray E.: Cutaneous MCTs: associations with spay/neuter status, breed, body size, and phylogenetic cluster. J Am Anim Hosp Assoc 2011, 47, 210–216.10.5326/JAAHA-MS-562121498594Search in Google Scholar

35. Zinc M.C., Farhoody P., Elser S.E., Ruffini L.D., Gibbons T.A., Rieger R.H.: Evaluation of the risk and age of onset of cancer and behavioral disorders in gonadectomized Vizslas. J Am Vet Med Assoc 2014, 244, 309–319.10.2460/javma.244.3.30924432963Search in Google Scholar